10q10k10q10k.net
ARGENX SE

ARGENX SEARGXEarnings & Financial Report

Nasdaq · pharmaceutical industry

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Q4 2025Q2 2025Q4 2024Q2 2024Q2 2023Q2 2022

Revenue

$1.8B

Gross Profit

$1.6B

Operating Profit

$340.0M

Net Profit

$414.8M

Gross Margin

89.2%

Operating Margin

19.2%

Net Margin

23.4%

YoY Growth

96.7%

EPS

$6.32

Financial Flow

ARGENX SE Q2 2025 Financial Summary

ARGENX SE reported revenue of $1.8B (up 96.7% YoY) for Q2 2025, with a net profit of $414.8M (up 1375.2% YoY) (23.4% margin). Cost of goods sold was $191.6M, operating expenses totaled $1.2B.

Key Financial Metrics

Total Revenue$1.8B
Net Profit$414.8M
Gross Margin89.2%
Operating Margin19.2%
Report PeriodQ2 2025

ARGENX SE Quarterly Revenue & Net Profit History

ARGENX SE results over the last 6 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q4 2025$2.5B+83.2%$877.2M35.5%
Q2 2025$1.8B+96.7%$414.8M23.4%
Q4 2024$1.4B—$865.6M64.1%
Q2 2024$901.9M+76.5%$-32.5M-3.6%
Q2 2023$510.9M+337.9%$-123.2M-24.1%
Q2 2022$116.7M-76.6%$-435.9M-373.7%

Income Statement

Q2 2022Q2 2023Q2 2024Q4 2024Q2 2025Q4 2025
Revenue$116.7M$510.9M$901.9M$1.35B$1.77B$2.47B
YoY Growth-76.6%337.9%76.5%N/A96.7%83.2%

Balance Sheet

Q2 2022Q2 2023Q2 2024Q4 2024Q2 2025Q4 2025
Assets$3.25B$3.19B$4.80B$6.20B$7.18B$8.68B
Liabilities$279.0M$335.7M$534.3M$704.2M$1.08B$1.36B
Equity$2.97B$2.86B$4.26B$5.50B$6.10B$7.32B

Cash Flow

Q2 2022Q2 2023Q2 2024Q4 2024Q2 2025Q4 2025
Operating CF$-494.5M$-285.4M$-124.7M$41.9M$361.8M$323.3M